That’s an absolute lie and you know it. We were around 40 cents before Vyvanse approval. And in the .60s after approval. Way before any talk of selling the company or whatever. We started to go up based the approval and subsequent launches We had a string of several launches - Percocet, norco, vyvanse, etc. clearly you forgot about all that or deliberately love to lie.
All that has happened since then, doubled earnings, pending ANDA for eliquis, new facility and now a bunch of shorts and bashers.
Facts are facts. And the fact is you are dishonest.
Market Data 
Markets 
AI
